Zobrazeno 1 - 10
of 39
pro vyhledávání: '"Loïc Lebellec"'
Autor:
Clémence Fournier, Clémence Leguillette, Eric Leblanc, Marie-Cécile Le Deley, Aurélien Carnot, David Pasquier, Alexandre Escande, Sophie Taieb, Luc Ceugnart, Loïc Lebellec
Publikováno v:
Cancers, Vol 15, Iss 11, p 2997 (2023)
After chemotherapy, patients with non-seminomatous germ cell tumors (NSGCTs) with residual masses >1 cm on computed tomography (CT) undergo surgery. However, in approximately 50% of cases, these masses only consist of necrosis/fibrosis. We aimed to d
Externí odkaz:
https://doaj.org/article/b597d8bb8c164373b8b93e6a0ffd465b
Autor:
Antonin Vary, Loïc Lebellec, Frédéric Di Fiore, Nicolas Penel, Claire Cheymol, Emilia Rad, Farid El Hajbi, Astrid Lièvre, Julien Edeline, André Michel Bimbai, Marie-Cécile Le Deley, Anthony Turpin
Publikováno v:
Therapeutic Advances in Medical Oncology, Vol 13 (2021)
Background: Most patients with advanced pancreatic adenocarcinoma (PA) treated with FOLFIRINOX experience adverse events requiring dose reduction. We aimed to assess the association between relative dose intensity (RDI) and disease control in a Europ
Externí odkaz:
https://doaj.org/article/c503d95fdec94c7eb3de50d752b7ba3e
Publikováno v:
Frontiers in Oncology, Vol 10 (2020)
We reviewed all fully published clinical trials assessing anti-angiogenic agents in sarcoma patients (last issue, January 13, 2020). Anti-angiogenic macromolecules (e.g., bevacizumab or ombrabulin) provide disappointing results. Many multikinase inhi
Externí odkaz:
https://doaj.org/article/830c492b42a246b79f716321665ba867
Autor:
Loïc Lebellec, François Bertucci, Emmanuelle Tresch-Bruneel, Isabelle Ray-Coquard, Axel Le Cesne, Emmanuelle Bompas, Jean-Yves Blay, Antoine Italiano, Olivier Mir, Thomas Ryckewaert, Yves Toiron, Luc Camoin, Anthony Goncalves, Nicolas Penel, Marie-Cécile Le Deley
Publikováno v:
BMC Cancer, Vol 18, Iss 1, Pp 1-10 (2018)
Abstract Background We report here a correlation analysis conducted along with a phase II trial assessing bevacizumab in combination with weekly paclitaxel. Methods Circulating pro/anti-angiogenic factors were assessed on day 1 (D1) and day 8 (D8). T
Externí odkaz:
https://doaj.org/article/8bc9c15293a74110ae91f43eb5bfec0e
Autor:
Cyrielle Scouarnec, David Pasquier, Joel Luu, Florence le Tinier, Loïc Lebellec, Erwann Rault, Eric Lartigau, Xavier Mirabel
Publikováno v:
Frontiers in Oncology, Vol 9 (2019)
Purpose: This study aimed to describe our institutional experience in the use of stereotactic body radiation therapy (SBRT) for the management of adrenal gland metastases from multiple primary cancers.Materials and Methods: We retrospectively reviewe
Externí odkaz:
https://doaj.org/article/272da0eea24d4d4bbe67b2dd0f62372d
Autor:
Do‐Youn Oh, Alain Algazi, Jaume Capdevila, Federico Longo, Wilson Miller, Jerry Tan Chun Bing, Carlos Eduardo Bonilla, Hyun Cheol Chung, Tormod K. Guren, Chia‐Chi Lin, Daniel Motola‐Kuba, Manisha Shah, Julien Hadoux, Lili Yao, Fan Jin, Kevin Norwood, Loïc Lebellec
Publikováno v:
Scientia
Immunotherapy; Pembrolizumab; Thyroid neoplasms Inmunoterapia; Pembrolizumab; Neoplasias de tiroides Immunoteràpia; Pembrolizumab; Neoplàsies de tiroides Background The authors report results from the thyroid carcinoma cohort of the multicohort pha
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::07ccc0a71c00fff9f932eb0906f8c2ac
https://hdl.handle.net/11351/9805
https://hdl.handle.net/11351/9805
Publikováno v:
Annals of Oncology.
Publikováno v:
Current opinion in oncology.
Human epidermal growth factor 2 (HER2) alterations (protein overexpression, gene amplification and mutation) play a key role in oncogenesis and are more likely correlated to poorer outcome in solid tumors. We reviewed recently published studies in th
Autor:
Antonin Broyelle, Nicolas Delanoy, André-Michel Bimbai, Marie-Cécile Le Deley, Nicolas Penel, Arnauld Villers, Loïc Lebellec, Stéphane Oudard
Publikováno v:
Clinical Genitourinary Cancer. 21:349-356.e2
Re: Chemotherapy in patients with localized angiosarcoma of any site. A retrospective European study
Publikováno v:
European journal of cancer (Oxford, England : 1990). 175